The compounds regulatory status is uncertain, and any commercial use targeting human consumers risks regulatory action
Such patterns point to the potential of regional KP activity as a functional biomarker for stress-related symptom dimensions in MDD and highlight localized KP enzymes such as IDO, TDO, and kynureninase as candidate treatment targets
Like any skincare regimen, patience and realistic expectations are key
How to read the research responsibly The constructive way to hold all of this is as a genuinely interesting preclinical mechanistic question with a tentative answer yes, the literature suggests distinct neuro-mechanisms wrapped in a hard boundary: no human efficacy, no approval, no clinical claim
(Taurine is another option to give you an energy boost.) As always, speak with your doctor first
doi: 10.1111/bcp.12070 181 EricksonCAWinkLKRayBEarlyMCStiegelmeyerEMathieu-FrasierLet al